1. Zhang, Wenqian, Li, Tong, Hu, Bin, Li, Hui. . PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma. In Technology in cancer research & treatment, 19, 1533033820957030. doi:10.1177/1533033820957030. https://pubmed.ncbi.nlm.nih.gov/33084541/
2. Shen, Hui, He, Min, Lin, Ruirong, Mohan, Man, Wang, Jian. 2019. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. In Journal of experimental & clinical cancer research : CR, 38, 247. doi:10.1186/s13046-019-1250-8. https://pubmed.ncbi.nlm.nih.gov/31182136/
3. Mao, Deli, Zhou, Zhijun, Chen, Hengxing, Liu, Mingyang, Zhang, Changhua. 2023. Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer. In Cancer letters, 572, 216351. doi:10.1016/j.canlet.2023.216351. https://pubmed.ncbi.nlm.nih.gov/37591356/
4. Cai, Tiantian, Yao, Wendong, Qiu, Lei, Shi, Zheng, Du, Yi. 2022. PLEK2 promotes the proliferation and migration of non-small cell lung cancer cells in a BRD4-dependent manner. In Molecular biology reports, 49, 3693-3704. doi:10.1007/s11033-022-07209-3. https://pubmed.ncbi.nlm.nih.gov/35122599/
5. Liu, Jianhua, Chen, Hao, Qiao, Guibin, Tian, Jie, Wu, Yi-Long. 2022. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma. In Cancer immunology, immunotherapy : CII, 72, 881-893. doi:10.1007/s00262-022-03288-0. https://pubmed.ncbi.nlm.nih.gov/36121452/
6. Yang, Xiao-Li, Ma, Yu-Shui, Liu, Yu-Shan, Liu, Ji-Bin, Fu, Da. 2021. microRNA-873 inhibits self-renewal and proliferation of pancreatic cancer stem cells through pleckstrin-2-dependent PI3K/AKT pathway. In Cellular signalling, 84, 110025. doi:10.1016/j.cellsig.2021.110025. https://pubmed.ncbi.nlm.nih.gov/33915247/
智鼠故事 
